Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus Directory of Open Access Journals kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Development and Validation of a Disease-specific Outcomes Tool for the Assessment of Patient Benefits of Treatment for Hidradenitis Suppurativa: the PBI-HS

Title: Development and Validation of a Disease-specific Outcomes Tool for the Assessment of Patient Benefits of Treatment for Hidradenitis Suppurativa: the PBI-HS
Authors: Natalia Kirsten; Matthias Augustin; Christine Blome; Janine Topp; Richard Schwager; Falk G. Bechara; Gefion Girbig; Andreas Pinter; Florian Anzengruber; Mareen Lindegaard; Christos C. Zouboulis; Marina Otten
Source: Acta Dermato-Venereologica, Vol 105 (2025)
Publisher Information: Medical Journals Sweden, 2025.
Publication Year: 2025
Collection: LCC:Dermatology
Subject Terms: hidradenitis suppurativa; life quality; patient outcome assessment; patient-reported outcomes; Dermatology; RL1-803
Description: Hidradenitis suppurativa is a chronic skin disease associated with significant disease burden. To assess patients’ treatment benefits, disease-specific outcomes measurement is needed. This study aimed to develop a questionnaire called Patient Benefit Index for hidradenitis suppurativa (PBI-HS). After an open-item survey, the items were condensed into a 26-item questionnaire on patient needs and benefits, with a 5-point Likert scale. In the validation study, construct and content validity, responsiveness, and feasibility of the questionnaire were assessed at 2 time points. A 26-item questionnaire was created following open-item generation by n = 72 patients. In the validation study, 3 items perceived as most relevant by patients were: “to be free of pain” (mean: 3.6 on a scale of 0–4), “to be free of inflammation” (mean: 3.6), “to have no more scars” (mean: 3.1). Significant correlations of PBI-HS at follow-up visit were found with the physical global assessment for hidradenitis suppurativa (HS-PGA) (r = –0.471; p = 0.000), number of inflammatory lesions (r = –0.359; p = 0.005), and DLQI (r = –0.383; p = 0.003), indicating less disease burden in patients with higher treatment benefits. The PBI-HS is a feasible and valid instrument to assess patient-reported treatment benefits in hidradenitis suppurativa.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 0001-5555; 1651-2057
Relation: https://medicaljournalssweden.se/actadv/article/view/41298; https://doaj.org/toc/0001-5555; https://doaj.org/toc/1651-2057
DOI: 10.2340/actadv.v105.41298
Access URL: https://doaj.org/article/ed0dd4aba06c490789dea6713fc3391c
Accession Number: edsdoj.0dd4aba06c490789dea6713fc3391c
Database: Directory of Open Access Journals